Browse studies

Find your next paid study

1 recruiting study matching your filters

Phase I/II Study of the Selective RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities

Phase 1 and 2 trial to study the safety, pharmacokinetics, and efficacy of TAS0953/HM06 in patients with advanced solid tumors with RET gene abnormalities. Pha…

RET-altered Non Small Cell Lung CancerRET-altered Solid Tumors

Taiho Pharmaceutical Co., Ltd.NCT04683250